• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human rRNA/tRNA 2′-O-methyltransferase fibrillarin-like protein 1 (FBLL1)

ACP19917

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19917 Target NameFBLL1
Target SynonymsFBLL1rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1; EC 2.1.1.-; Protein-glutamine methyltransferaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-333
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDA6NHQ2
Background Information
  • Uniprot Id

    A6NHQ2

  • Target Species

    Human

  • Target Name

    FBLL1

  • Target Full Name

    rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1

  • Target Function

    S-adenosyl-L-methionine-dependent methyltransferase that has the ability to methylate both RNAs and proteins. Involved in pre-rRNA processing by catalyzing the site-specific 2'-hydroxyl methylation of ribose moieties in pre-ribosomal RNA. Also acts as a protein methyltransferase by mediating methylation of glutamine residues.

  • Target Subcellular Location

    Nucleus, nucleolus.

  • Target Protein Families

    Methyltransferase superfamily, Fibrillarin family

  • Target Synonyms

    FBLL1rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1; EC 2.1.1.-; Protein-glutamine methyltransferase

Inquire Recombinant Human rRNA/tRNA 2′-O-methyltransferase fibrillarin-like protein 1 (FBLL1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification